SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurex Corporation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffers Hughes who wrote (362)10/9/1997 11:08:00 AM
From: Giuseppe Scalamogna   of 449
 
And looking even further ahead, SNX-111 Phase III for chronic pain which was the latest release after having completed phase II trials will complete enrollment in this quarter and will see completion sometime time I think in the first-half of next year.

The stock has been trending forward now for several days. Shows nice uptick in demand at these higher prices. With some consistent good news though the stock can pop over 20 and beyond at any minute. Biotechs right now are very prone to massive 1-day gains as someone here has pointed out. With pivotal phase III results coming due hold on to your hats.

Be patient and Good Luck

GS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext